The document discusses guidelines for deep vein thrombosis (DVT) prophylaxis for orthopedic trauma patients. It notes that many existing guidelines do not adequately address trauma patients, who have higher DVT risks due to immobility from injury. A review found that 77% of patients transferred to the authors' hospitals did not receive pre-transfer DVT prophylaxis, including 67% of hip fracture patients despite being at high risk. The authors developed new DVT prophylaxis guidelines for orthopedic trauma patients to help standardize care and lower DVT risks.
Periprosthetic fractures are the third most common reason for revision total hip arthroplasty. Surgical treatment of periprosthetic fractures belongs to the most difficult procedures due to the extensive surgery, elderly polymorbid patients and the high frequency of other complications. The aim of this study was to evaluate the results of operatively treated periprosthetic femoral fractures after total hip arthroplasty.
We evaluated 47 periprosthetic fractures in 40 patients (18 men and 22 women) operated on between January 2004 and December 2010. The mean follow-up period was 27 months (within a range of 12-45 months). For the clinical evaluation, we used modified Merle d'Aubigné scoring system.
In group of Vancouver A fractures, 3 patients were treated with a mean score of 15,7 points (good result). We recorded a mean score of 14,2 points (fair result) in 6 patients with Vancouver B1 fractures, 12,4 points (fair result) in 24 patients with Vancouver B2 fractures and 12,8 points (fair result) in 7 patients with Vancouver B3 fractures. In group of Vancouver C fractures, we found a mean score of 16,2 points (good result) in 7 patients.
Therapeutic algorithm based on the Vancouver classification system is, in our opinion, satisfactory. Accurate differentiation of B1 and B2 type of fractures is essential. Preoperative radiographic images may not be reliable and checking the stability of the prosthesis fixation during surgery should be performed.
Background: Distal femur fractures make up 6 to 7% of all femur fractures. Various plating options for distal femur fracture are conventional buttress plates, fixed-angle devices, and locking plates. This study was planned to evaluate and explore locking compression plate fixation in distal end femur fractures which is expected to provide a stable fixation with minimum exposure, early mobilization, less complications and a better quality of life.
Methods: The study was conducted as prospective clinical study in 20 skeletally mature patients with x-ray evidence of distal femur fracture fulfilling inclusion and exclusion criteria, operated with distal femur LCP plating. Patients were assessed radiologically and classified according to distal femur fracture classification and outcome graded as excellent, good, fair and poor based on Lysholm Knee Score.
Results: Out of 15 excellent outcome cases, 3 cases were type A1 fracture, 1 case had type A3, 2 cases had type B1 and B2 each, 5 cases had type C2 and 2 cases had type C3 fracture. 1 case with good outcome was type C3. 1 case with fair outcome was type B2. While 3 cases with poor outcome were type A1, A2 and C3.
Conclusions: The DF-LCP is an ideal implant to use for fractures of the distal femur. However, accurate positioning and fixation are required to produce satisfactory results. We recommend use of this implant in Type A and C, osteoporotic and periprosthetic fractures.
Keywords: Distal femur, DF-LCP, Lysholm score, Periprosthetic fracture
Comparison Results between Patients with Developmental Hip Dysplasia Treated ...CrimsonPublishersOPROJ
Comparison Results between Patients with Developmental Hip Dysplasia Treated with Either Salter or Pemberton Osteotomy by Dello Russo Bibiana* in Orthopedic Research Online Journal
Periprosthetic fractures are the third most common reason for revision total hip arthroplasty. Surgical treatment of periprosthetic fractures belongs to the most difficult procedures due to the extensive surgery, elderly polymorbid patients and the high frequency of other complications. The aim of this study was to evaluate the results of operatively treated periprosthetic femoral fractures after total hip arthroplasty.
We evaluated 47 periprosthetic fractures in 40 patients (18 men and 22 women) operated on between January 2004 and December 2010. The mean follow-up period was 27 months (within a range of 12-45 months). For the clinical evaluation, we used modified Merle d'Aubigné scoring system.
In group of Vancouver A fractures, 3 patients were treated with a mean score of 15,7 points (good result). We recorded a mean score of 14,2 points (fair result) in 6 patients with Vancouver B1 fractures, 12,4 points (fair result) in 24 patients with Vancouver B2 fractures and 12,8 points (fair result) in 7 patients with Vancouver B3 fractures. In group of Vancouver C fractures, we found a mean score of 16,2 points (good result) in 7 patients.
Therapeutic algorithm based on the Vancouver classification system is, in our opinion, satisfactory. Accurate differentiation of B1 and B2 type of fractures is essential. Preoperative radiographic images may not be reliable and checking the stability of the prosthesis fixation during surgery should be performed.
Background: Distal femur fractures make up 6 to 7% of all femur fractures. Various plating options for distal femur fracture are conventional buttress plates, fixed-angle devices, and locking plates. This study was planned to evaluate and explore locking compression plate fixation in distal end femur fractures which is expected to provide a stable fixation with minimum exposure, early mobilization, less complications and a better quality of life.
Methods: The study was conducted as prospective clinical study in 20 skeletally mature patients with x-ray evidence of distal femur fracture fulfilling inclusion and exclusion criteria, operated with distal femur LCP plating. Patients were assessed radiologically and classified according to distal femur fracture classification and outcome graded as excellent, good, fair and poor based on Lysholm Knee Score.
Results: Out of 15 excellent outcome cases, 3 cases were type A1 fracture, 1 case had type A3, 2 cases had type B1 and B2 each, 5 cases had type C2 and 2 cases had type C3 fracture. 1 case with good outcome was type C3. 1 case with fair outcome was type B2. While 3 cases with poor outcome were type A1, A2 and C3.
Conclusions: The DF-LCP is an ideal implant to use for fractures of the distal femur. However, accurate positioning and fixation are required to produce satisfactory results. We recommend use of this implant in Type A and C, osteoporotic and periprosthetic fractures.
Keywords: Distal femur, DF-LCP, Lysholm score, Periprosthetic fracture
Comparison Results between Patients with Developmental Hip Dysplasia Treated ...CrimsonPublishersOPROJ
Comparison Results between Patients with Developmental Hip Dysplasia Treated with Either Salter or Pemberton Osteotomy by Dello Russo Bibiana* in Orthopedic Research Online Journal
This was powerpoint was requested by an attending physician to be shared with the Psychiatric providers regarding DVT prophylaxis in patients who may have been on the unit. They include recommendations as outlined by the ACCP 2012 Guidelines for prevention of venous thromboembolism
Sternal Fractures & Dislocations - EMGuidewire Radiology Reading RoomSean M. Fox
The Department of Emergency Medicine at Carolinas Medical Center is passionate about education! Dr. Michael Gibbs is a world-renowned clinician and educator and has helped guide numerous young clinicians on the long path of Mastery of Emergency Medical Care. With his oversight, the EMGuideWire team aim to help augment our understanding of emergent imaging. You can follow along with the EMGuideWire.com team as they post these educational, self-guided radiology slides or you can also use this section to learn more in-depth about specific conditions and diseases. This Radiology Reading Room pertains to Sternal Fractures and Dislocations and is brought to you by Carrie Bissell, MD, Aaron Fox, MD, Kendrick Lim, MD, Stephanie Jensen, MD, and Olivia Rice, MD. It is has special guest editor: Sean Dieffenbaugher, MD and Laurence Kempton, MD
Is routine thromboprophylaxis warranted in all patients of tibial fracture ma...iosrjce
IOSR Journal of Dental and Medical Sciences is one of the speciality Journal in Dental Science and Medical Science published by International Organization of Scientific Research (IOSR). The Journal publishes papers of the highest scientific merit and widest possible scope work in all areas related to medical and dental science. The Journal welcome review articles, leading medical and clinical research articles, technical notes, case reports and others.
Incidence of VTE in the First Postoperative 24 Hours after Abdominopelvic Sur...semualkaira
A good number of research reports the incidence of postoperative venous thromboembolism (VTE) mostly looks at longer postoperative duration, usually days after surgery.
Clinical and epidemiological profile of patients undergoing total hip arthro...David Sadigursky
Clinical and epidemiological profile of patients undergoing total hip arthroplasty.
Rheumatology and Orthopedic Medicine
Rheumatol Orthop Med, 2017 doi: 10.15761/ROM.1000120
Slides from Prof Dan Pratt presented at the Teaching to Teach Workshop in Boston, MA, May 1-2, 2009;
Massachusetts General Hospital, Harvard Medical School.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Anti ulcer drugs and their Advance pharmacology ||
Anti-ulcer drugs are medications used to prevent and treat ulcers in the stomach and upper part of the small intestine (duodenal ulcers). These ulcers are often caused by an imbalance between stomach acid and the mucosal lining, which protects the stomach lining.
||Scope: Overview of various classes of anti-ulcer drugs, their mechanisms of action, indications, side effects, and clinical considerations.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
EATING DISORDERS (Psychiatry-7)by dr Shivam sharma.pptxShivam Sharma
For any queries ,contact shvmshrm@outlook.com
---
## Introduction to Eating Disorders
Welcome to this comprehensive presentation on Eating Disorders, a critical and often misunderstood area of mental health. This presentation is designed to provide in-depth knowledge and insights into the various aspects of eating disorders, making it valuable for both postgraduate medical aspirants preparing for the INI-CET and the general public seeking to understand these complex conditions.
### Objectives:
1. **Understanding Eating Disorders**: Gain a clear understanding of what eating disorders are, their types, and their distinguishing characteristics.
2. **Etiology and Risk Factors**: Explore the underlying causes and risk factors that contribute to the development of eating disorders.
3. **Clinical Features and Diagnosis**: Learn about the clinical features, diagnostic criteria, and the importance of early detection.
4. **Management and Treatment**: Review the current approaches to managing and treating eating disorders, including medical, psychological, and nutritional interventions.
5. **Prevention and Awareness**: Discuss strategies for prevention, early intervention, and increasing awareness about eating disorders.
This presentation aims to bridge the gap between academic knowledge and practical understanding, providing you with the tools to recognize, diagnose, and effectively manage eating disorders. Whether you are preparing for a medical exam or seeking to educate yourself or others about these serious conditions, this presentation will equip you with essential information and practical insights.
Let's begin our journey into understanding eating disorders and the significant impact they have on individuals and society.
---
For any queries ,contact shvmshrm@outlook.com
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx
Guidelines for DVT Prophylaxis
1. Trauma RoundsReports from the Harvard Medical School Orthopedic Trauma Initiative
A Quarterly Case Study Volume 6, Summer 2015
Marilyn Heng, MD, FRCSC
Michael Weaver, MD
One of the goals of the Harvard
Medical School Orthopedic
Trauma Initiative (HMSOTI) is
to develop clinical practice
guidelines to decrease variation
in orthopedic trauma care within our clinical practices. Our
Partners Orthopaedic Trauma Service (Massachusetts General
Hospital and Brigham & Women’s Hospital) has had a protocol
for deep vein thrombosis (DVT) prophylaxis for more than ten
years. We have recently updated this protocol with the best-
available evidence and HMSOTI surgeon buy-in, to develop a
common protocol for our entire community (included & online).
DVT is a common cause of morbidity and mortality in hos-
pitalized patients and is a well-known complication after frac-
tures of the pelvis and lower extremity. Among patients with a
hip fracture, venous thromboembolism (VTE) represents one of
the more common causes of death after surgery.1,2
The detection of this life-threatening condition is often
complicated in the trauma setting as frequently patients already
have lower extremity swelling caused by their injuries. Major
lower extremity trauma and prolonged immobility are well-
recognized risk factors for DVT. This is in addition to the fact
that up to half of DVTs present asymptomatically.
A study of two hospitals in Queensland, Australia found a
78% adherence to appropriate prophylaxis in orthopedic pa-
tients3 while a large review of an international, longitudinal
registry reported an 86% compliance with the 2008 American
College of Chest Physicians (CHEST) guidelines for VTE pro-
phylaxis in patients who underwent total joint arthroplasty
(TJA) or hip fracture surgery.4 These are rates of appropriate
prophylaxis use in the context of published guidelines.
The American Academy of Orthopaedic Surgeons (AAOS)
has guidelines for VTE prophylaxis in patients undergoing elec-
tive hip and knee arthroplasty, but they do not have guidelines
for patients who have been injured. The CHEST guidelines in-
clude hip fracture surgery as a major orthopedic procedure that
confers an increased risk of VTE to patients and recommends
the use of thromboprophylaxis. However, these guidelines fo-
cus on the event of surgery in patients with a hip fracture and
thus are mainly concerned with the recommendation of post-
operative prophylaxis. Similar to their recommendations for
TJA patients, they recommend the start of thromboprophylaxis
as “either 12h or more preoperatively, or 12h or more
postoperatively.”5 They do not take into account a key differ-
ence between orthopedic trauma patients and TJA patients:
from the time of injury, patients with major lower extremity
fractures are generally immobile until after their surgery. The
National Institute for Health and Clinical Evidence (NICE)
guidelines in the United Kingdom are the only major guidelines
that offer explicit direction for hip fracture patients without
contraindication to anticoagulation to start pharmacological
VTE prophylaxis at admission (using low-molecular weight
heparin or unfractionated heparin), stopping 12 hours before
surgery and then re-starting 6-12 hours after surgery.6
In a review of our own data, we have focused on a subset of
patients who are not explicitly addressed in many of the guide-
lines: orthopedic trauma patients who have transferred from a
community hospital to a tertiary care center. Our most recent
audit has shown a surprising result: approximately 77% of these
patients have not had VTE prophylaxis prior to transfer. Even
among patients with a hip fracture – patients whom the CHEST
clearly places in a high-risk group - pre-transfer thrombopro-
phylaxis was administered only 33% of the time. We are thus
unclear as to why this is so, and wonder whether the anticipa-
tion of transfer and uncertainty of the transferring physician
contributes to a lack of VTE prophylaxis in these patients.
The incidence of DVT among patients transferred to our
hospitals was 18%. Our data show that patients who develop a
DVT upon transfer from an outside hospital were more likely to
be older and have a hip fracture. The impact of age as a risk
factor for VTE has been variable in previous studies – in various
patient populations, several studies have shown it to be an in-
dependent risk factor for VTE,7,8,9,10 while others have gotten a
Trauma Rounds, Volume 6, Summer 2015
1
H M S O R T H O P E D I C T R A U M A I N I T I A T I V E
Guidelines for DVT Prophylaxis
2. different result.11,12,13 This corroborates studies that identify age
as an independent risk factor for DVT.
Rates of asymptomatic DVT occurrence in patients with
lower extremity fractures have been reported as high as 69% in
those who do not receive prophylaxis. A 1995 study of asymp-
tomatic DVT’s in trauma (not exclusively orthopedic) patients
receiving DVT prophylaxis reported an incidence of 10%.14 It
should be noted that our 18% incidence is in a largely unpro-
phylaxed population and it is a rate of both symptomatic and
asymptomatic DVT. Additionally, it is the rate of DVT upon
transfer, meaning that the majority of patients developed their
DVT within the first 3 days from their injury (the median length
of stay at the outside hospital was 2.0 days). This highlights
previous reports that early DVT/PE (pulmonary embolism)
within 48 hours of an inciting circumstance can and does occur.
Menaker et al. reported data that suggest up to 37% of PE after
injury occurs within the first two days of hospitalization. Thus,
early detection and treatment of DVT’s may lower the risks of
development of PE.15
Our DVT prophylaxis guidelines have been developed in
consideration of the CHEST and NICE guidelines. We simpli-
fied the algorithm to ensure ease-of-use for surgeons, residents,
and mid-level providers. Certain institutional specific resources
such as the Coumadin Management Clinic at Brigham &
Women’s and department-wide practices (i.e. Coumadin use
postoperatively for all TJA patients at Brigham & Women’s) are
the rationale for some variation in the guidelines between our
hospitals. We will continue to update these guidelines as
needed based on emerging evidence in the literature and our
own population-specific DVT/VTE rates.
References
1. Dahl OE, Caprini JA, Colwell CW, Frostick SP, Haas S, Hull RD,
Laporte S, Stein PD. Fatal vascular outcomes following major
orthopedic surgery. Thrombosis and Haemostasis. 2005; 93: 860-866.
2. Perez JV, Warwick DJ, Case CP, Bannister GC. Death after proxi-
mal femoral fracture – an autopsy study. Injury. 1995; 26: 237-240.
3. Phillips NM, Heazlewood VJ. Venous thromboembolism prophy-
laxis audit in two Queensland hospitals. Internal Medicine Journal.
2013; 43(5): 560-566.
4. Falck-Ytter Y, Francis CW, Johanson NA, Curley C, Dahl OE,
Schulman S, Ortel TL, Pauker SG, Colwell CW. Prevention of VTE
in Orthopedic Surgery Patients: Antithrombotic Therapy and Pre-
vention of Thrombosis 9th ed: American College of Chest Physi-
cians Evidence-Based Clinical Practice Guidelines. Chest. 2012;
141(2)(Suppl): e278S-e325S.
5. Preventing venous thromboembolic disease in patients undergo-
ing elective hip and knee arthroplasty: Evidence-based guideline
and evidence report, 2nd ed. 2011, American Academy of Ortho-
paedic Surgeons, Rosemount, IL.
6. Venous thromboembolism: Reducing the risk of venous throm-
boembolism (deep vein thrombosis and pulmonary embolism in
patients admitted to hospital). [NICE clinical guideline 92]. Lon-
don: National Institute for Health and Care Excellence; 2010.
7. Geerts WH, Code KI, Jay RM, Chen E, Szalai JP. A Prospective
study of venous thromboembolism after major trauma. New Eng-
land Journal of Medicine. 1994; 331(24): 1601-1606.
8. Napolitano LM, Garlapati VS, Heard SO, Silva WE, Cutler BS,
O’Neill AM, Anderson FA, Wheeler HB. Asymptomatic deep ve-
nous thrombosis in the trauma patient: Is an aggressive screening
protocol justified? Journal of Trauma, Injury, Infection and Critical
Care. 1995; 39(4): 651-659.
9. Markovic-Denic L, Zivkovic K, Lesic A, Bumbasirevic V,
Dubljanin-Raspopovic ER, Bumbasirevic M. Risk factors and dis-
tribution of symptomatic venous thromboembolism in total hip
and knee replacements: prospective study. International Orthopae-
dics. 2012; 36: 1299-1305.
10. Haut ER, Chang DC, Pierce CA, Colantuoni E, Efron DT, Haider
AH, Cornwell EE 3rd, Pronovost PJ. Predictors of posttraumatic
deep vein thrombosis (DVT): hospital practice versus patient fac-
tors – an analysis of the National Trauma Data Bank (NTDB).
Journal of Trauma. 2009; 66: 994-1001.
11. Azu MC, McCormack JE, Huang EC, Lee TK, Shapiro MJ. Venous
thromboembolic events in hospitalized trauma patients. The
American Surgeon. 2007; 73: 1228-1231.
12. Baldwin K, Namdari S, Esterhai JL, Metha S. Venous thromboem-
bolism in patients with blunt trauma: Are comprehensive guide-
lines the answer? American Journal of Orthopedics. 2011; 40(5): e83-
87.
13. Prensky C, Urruela A, Guss MS, Karia R, Lenzo TJ, Egol KA.
Symptomatic venous thrombo-embolism in low-energy isolated
fractures in hospitalised patients. Injury. 2013; 44: 1135-1139.
14. Napolitano LM, Garlapati VS, Heard SO, Silva WE, Cutler BS,
O’Neill AM, Anderson FA, Wheeler HB. Asymptomatic deep ve-
nous thrombosis in the trauma patient: Is an aggressive screening
protocol justified? Journal of Trauma, Injury, Infection and Critical
Care. 1995; 39(4): 651-659.
15. Menaker J, Stein DM, Scalea TM. Incidence of early pulmonary
embolism after injury. Journal of Trauma, Injury, Infection, and Criti-
cal Care. 2007; 63: 620-624.
Marilyn Heng, MD, FRCSC is an Orthopedic Trauma surgeon in the De-
partment of Orthopaedic Surgery, Massachusetts General Hospital, Boston,
MA and Instructor in Orthopedic Surgery at Harvard Medical School.
Michael Weaver, MD is an Orthopedic Trauma surgeon in the Department of
Orthopaedic Surgery, Brigham & Women’s Hospital, Boston, MA, and In-
structor in Orthopedic Surgery at Harvard Medical School. He is also Direc-
tor of the Harvard Orthopedic Trauma Fellowship Program.
H M S O R T H O P E D I C T R A U M A I N I T I A T I V E
2
Trauma Rounds, Volume 6, Summer 2015
Editor in Chief
MarkVrahas, MD
Program Director
Suzanne Morrison, MPH
(617) 525-8876
smmorrison@partners.org
Editor, Publisher
Arun Shanbhag, PhD, MBA
Share your comments online, by email, or mail:
HarvardOrthoTrauma@partners.org
Yawkey Center for Outpatient Care,
Ste 3C
55 Fruit Street, Boston, MA 02114
www.MassGeneral.org/ortho
www.BrighamAndWomens.org/orthopedics
www.Bidmc.org/orthopaedics
AchesAndJoints.org/Trauma